DRI Healthcare Trust completes C$98 million bought deal public offering of units

On July 19, 2023, DRI Healthcare Trust (the "Trust") announced that it completed its previously announced bought deal public offering of units of the Trust at a price of C$10.60 per unit. The underwriters, led by CIBC Capital Markets, Scotiabank and RBC Capital Markets and including National Bank Financial Inc., Canaccord Genuity Corp., Raymond James Ltd., UBS Securities Canada Inc. and Stifel GMP, elected to exercise their over-allotment option in full, resulting in a total of 9,223,000 units being issued for gross proceeds to the Trust of C$98 million.

The Trust intends to use the net proceeds of the offering to fund royalty transactions or to repay indebtedness drawn on its secured credit facility to fund royalty transactions.

Further information can be found on Canada Newswire’s website.

DRI Healthcare Trust is managed by DRI Capital Inc., a pioneer in global pharmaceutical royalty monetization with a more than 30-year history of accelerating innovation by providing capital to inventors, academic institutions and biopharma companies.